Table 3.
Multivariate Cox regression analysis for ECG-4 and ECG-5
| ECG-4 | ECG-5 | |||
|---|---|---|---|---|
| Variables | HR (95% CI) | p | HR (95% CI) | p |
| Age at each visit | 1.05 (1.01–1.07) | 0.002 | 1.04 (1.007–1.06) | 0.01 |
| AMS (2 years prior to ECG) | 1.08 (1.02–1.16) | 0.009 | 1.07 (1.002–1.14) | 0.04 |
| SDI | 1.29 (1.10–1.53) | 0.002 | 1.28 (1.08–1.51) | 0.004 |
| Hyperlipidemia on statins ever before ECG | 0.44 (0.21–0.89) | 0.02 | 0.44 (0.22–0.87) | 0.02 |
| Hypertension | 0.66 (0.34–1.26) | 0.21 | 0.75 (0.4–1.39) | 0.36 |
| Ever smoked before ECG | 1.13 (0.59–2.16) | 0.71 | 1.09 (0.58–2.06) | 0.77 |
| Immunosuppressive treatment at each visit | 1.88 (1.01–3.51) | 0.05 | 1.67 (0.93–3.04) | 0.09 |
| Antimalarial treatment at each visit | 1.76 (0.87–3.58) | 0.12 | 1.81 (0.92–3.56) | 0.12 |
Akaike information criterion (AIC) = 334.6
AMS adjusted mean SLEDAI-2 K, CI confidence interval, ECG electrocardiogram, HR hazard ratio, SDI SLICC/American College of Rheumatology Damage Index, SLE systemic lupus erythematosus, SLEDAI-2 K SLE Disease Activity Index 2000